Here at CVB, we tend to think of our audience as cardiology’s practitioners, not its patients. But the truth is, the public is reading our content as frequently as physicians. Our job is the same, no matter the audience—to tell cardiology’s stories.
Mateon Therapeutics, a California-based biopharmaceutical company, has completed its acquisition of PointR Data, a technology company focused on AI and other advanced technologies.
Remote monitoring and high-tech health management solutions have dominated cardiology headlines for the better part of the past year, touted for their accessibility and preventive benefits. But that vision of remote monitoring as the future of CV care might be a skewed representation of our current reality.
Clariscan is a gadolinium-based agent indicated for IV use in brain, spine and associated tissues to help detect areas with disruption of the blood brain barrier, or abnormal vascularity.
CMS has finalized payment rules for 2020, dropping a controversial coding change in the Physician Fee Schedule and a proposal to force hospitals to publicly disclose their standard pricing.